Research
Equity Research
DTE Energy Stock Analysis: Buy or Sell? Valuation, FCF & Leverage
DTE Energy (DTE) is rated Hold as regulated growth is offset by deeply negative free cash flow and elevated leverage. The utility’s franchise is durable,…
Weatherford Stock Analysis: Buy or Sell? Cash Flow, Valuation & Revenue
Weatherford International plc (WFRD) earns a Hold as strong free cash flow and modest leverage offset continued revenue contraction. The stock looks fairly valued, but…
Lantheus Stock Analysis: Buy or Sell? Valuation, Margins & Growth
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E…
Texas Instruments Stock Analysis: Buy or Sell? Valuation, Margins & China Risk
Texas Instruments (TXN) is rated Hold as its quality and cash generation are already reflected in a rich valuation. Strong operating margins and free cash…
Telephone and Data Systems Stock Analysis: Buy or Sell? Cash Flow, Fiber Buildout & Margin
Telephone and Data Systems (TDS) is rated hold as strong free cash flow and cash-rich balance sheet support are offset by negative operating margin and…
Public Service Enterprise Group Stock Analysis: Buy or Sell? Leverage & Cash Flow
Public Service Enterprise Group (PEG) is rated Hold as its regulated New Jersey franchise supports earnings visibility, but weak cash conversion limits upside. High leverage…
Schrödinger Stock Analysis: Buy or Sell? Valuation & Cash Burn
Schrödinger (SDGR) is rated Sell because its platform quality has not yet translated into durable cash generation. The valuation still assumes stronger growth, while operating…
Oshkosh Stock Analysis: Buy or Sell? Valuation, Tariffs & NGDV Risk
Oshkosh Corporation (OSK) is rated Hold as solid cash generation and a manageable balance sheet are offset by tariff pressure and NGDV execution risk. The…
LRCX — Equity Research
LRCX+307.58% KLAC+187.37% AMAT+243.21% Executive Summary Rating: SELL | LRCX I would put my rating as a Sell because Lam Research already trades at 46.5x forward…
Nutex Health Stock Analysis: Buy or Sell? Free Cash Flow, Valuation, Reimbursement Risk
Nutex Health Inc. (NUTX) is rated Buy in this stock analysis because it is already turning revenue into strong free cash flow, with a 15.6%…
Most Popular Research